SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creators of patented silver dihydrogen citrate (SDC), the active ingredient in a revolutionary new hard surface disinfectant which kills Staph/MRSA as well as other human pathogens, today announced that Michael L. Krall, President and CEO of PURE Bioscience, will present at the inaugural LD MICRO Small & Micro Cap Stock Conference in Los Angeles, on Tuesday, April 29th, at 10:30 a.m. PST at The Omni Los Angeles at California Plaza. Krall will meet with institutional investors to discuss the Company’s growth and development.
